Production (Stage)
BioSyent Inc.
RX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.11M | 11.08M | 12.63M | 12.72M | 17.49M |
| Total Receivables | 3.81M | 2.08M | 3.27M | 4.26M | 2.12M |
| Inventory | 3.67M | 3.70M | 4.19M | 4.41M | 4.22M |
| Prepaid Expenses | 337.20K | 140.40K | 290.10K | 592.50K | 420.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 4.00K | 16.50K | 16.10K | 8.50K |
| Total Current Assets | 19.93M | 17.01M | 20.39M | 21.99M | 24.26M |
|
|
|||||
| Total Current Assets | 19.93M | 17.01M | 20.39M | 21.99M | 24.26M |
| Net Property, Plant & Equipment | 769.90K | 1.64M | 903.20K | 933.10K | 949.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.35M | 6.89M | 4.05M | 694.30K | 760.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 490.40K | 894.80K | 537.50K | 549.70K | 533.80K |
| Total Assets | 29.75M | 28.75M | 33.66M | 30.31M | 29.54M |
|
|
|||||
| Total Accounts Payable | 3.31M | 2.78M | 4.63M | 3.27M | 2.65M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 140.40K | 136.70K | 141.80K | 137.50K | 137.20K |
| Total Finance Division Other Current Liabilities | 618.20K | 840.60K | 437.90K | 181.00K | 360.60K |
| Total Other Current Liabilities | 618.20K | 840.60K | 437.90K | 181.00K | 360.60K |
| Total Current Liabilities | 4.07M | 3.76M | 5.21M | 3.59M | 3.14M |
|
|
|||||
| Total Current Liabilities | 4.07M | 3.76M | 5.21M | 3.59M | 3.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 548.50K | 584.60K | 660.90K | 688.40K | 731.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 80.20K | 76.50K | 146.10K | 153.40K | 145.90K |
| Total Liabilities | 4.70M | 4.42M | 6.01M | 4.43M | 4.02M |
|
|
|||||
| Common Stock & APIC | 4.81M | 5.17M | 5.39M | 5.20M | 5.32M |
| Retained Earnings | 20.36M | 19.27M | 22.40M | 20.81M | 20.33M |
| Treasury Stock & Other | -119.80K | -119.20K | -150.10K | -129.30K | -130.90K |
| Total Common Equity | 25.05M | 24.33M | 27.64M | 25.88M | 25.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.05M | 24.33M | 27.64M | 25.88M | 25.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.05M | 24.33M | 27.64M | 25.88M | 25.52M |
|
|
|||||